HQ
HealthEquity
HQY · NASDAQ
$94.52 -0.55% (-$0.53)
1M -10.32%
Market Cap $7.90B
P/E Ratio 33.41x
Div. Yield -
ROE 11.43%
Bulios Fair Price
$77.8
17.7% downside
Current Price
$94.52
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HQY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
52 /100
Fair EV/EBITDA 16.37x
P/S 5.80x
P/B 3.97x
Growth
86 /100
Growing FCF growth 143.50%
Book val. growth 3.59%
Rev. growth 15.08%
Profitability
99 /100
Strong Net margin 17.36%
Op. margin 25.61%
FCF margin 34.63%
Quality
51 /100
Average ROE 11.43%
ROA 7.23%
Asset turnover 0.42x
Debt
93 /100
Low Current ratio 2.99x
Int. coverage 6.43x
Net debt/EBITDA -0.46x
Stability
39 /100
Moderate Rev. volatility 5.33%
EPS volatility 123.49%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HQY
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Scott R. Cutler
Employees
2,814
Headquarters
Draper
Upcoming events
02 DEC
Earnings
Upcoming earnings report